Recent findings and applications of biomedical engineering for COVID-19 diagnosis: a critical review

References

• Worldometers. COVID-19 Coronavirus Pandemic. 2021.
   Google Scholar
• Rebecca MN, Sutter KM, Sutherland MD. Global economic effects of COVID-19. Congressional Research Service; 2021. https://fas.org/sgp/crs/row/R46270.pdf
   Google Scholar
• Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126(10):1456–1474.
   PubMed Web of Science ®Google Scholar
• Sharma A, Tiwari S, Deb MK, et al. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents. 2020;56(2):106054.
   PubMed Web of Science ®Google Scholar
• Shaffaf T, Ghafar-Zadeh E. COVID-19 Diagnostic Strategies. In: Part I: nucleic Acid-Based Technologies. Bioengineering (Basel). 2021. p. 8.
   Google Scholar
• Mahbub MH, Khan M, Yamaguchi N, et al. Japans public health and culture, and the ongoing fight against COVID-19. J Adv Biotechnol Exp Ther. 2020;3(3):42–48.
   Google Scholar
• Mina F, Billah M, Rahman M, et al. COVID-19: transmission, diagnosis, policy intervention, potential broader perspective on the rapidly evolving situation in Bangladesh. J Adv Biotechnol Exp Ther. 2020;3(4):18–29.
   Google Scholar
• Rahman M, Sajib E, Chowdhury I, et al. Present scenario of COVID-19 in Bangladesh and government preparedness for facing challenges. J Adv Biotechnol Exp Ther. 2021;4(2):187–199.
   Google Scholar
• Sheam M, Syed S, Barman S, et al. COVID-19: the catastrophe of our time. J Adv Biotechnol Exp Ther. 2020;3(4):1–13.
   Google Scholar
• Sohel M, Hossain M, Hasan M, et al. Management of mental health during COVID 19 pandemic: possible strategies. J Adv Biotechnol Exp Ther. 2021;4(3):276–289.
   Google Scholar
• Zhao H, Lu X, Deng Y, et al. COVID-19: asymptomatic carrier transmission is an underestimated problem. Epidemiol Infect. 2020;148:e116.
   PubMed Web of Science ®Google Scholar
• Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13(5):667–673.
   PubMed Web of Science ®Google Scholar
• Sironi M, Hasnain SE, Rosenthal B, et al. SARS-CoV-2 and COVID-19: a genetic, epidemiological, and evolutionary perspective. Infect Genet Evol. 2020;84:104384.
   PubMed Web of Science ®Google Scholar
• BCC Research. COVID-19 diagnostic services: global markets. https://www.bccresearch.com/market-research/medical-devices-and-surgical/covid-19-diagnostics-market-report.html. 2021.
   Google Scholar
• Song YJ, Yang JS, Yoon HJ, et al. Asymptomatic middle east respiratory syndrome coronavirus infection using a serologic survey in Korea. Epidemiol Health. 2018;40:e2018014.
   PubMed Web of Science ®Google Scholar
• Wan Y, Shang J, Sun S, et al. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J Virol. 2020;94.
   Web of Science ®Google Scholar
• Cockrell AS, Yount BL, Scobey T, et al. A mouse model for MERS coronavirus-induced acute respiratory distress syndrome. Nat Microbiol. 2016;2(2):16226.
   PubMed Web of Science ®Google Scholar
• Fukushi S, Fukuma A, Kurosu T, et al. Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA. J Virol Methods. 2018;251:22–29.
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Kashir J, Yaqinuddin A. Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19. Med Hypotheses. 2020;141:109786.
   PubMed Web of Science ®Google Scholar
• Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 2018;360(6387):439–444.
   PubMed Web of Science ®Google Scholar
• Tang R, Yang H, Gong Y, et al. Improved analytical sensitivity of lateral flow assay using sponge for HBV nucleic acid detection. Sci Rep. 2017;7(1):1360.
   PubMedGoogle Scholar
• Ding X, Yin K, Li Z, et al., CRISPR-Cas12a (AIOD-CRISPR) assay: a case for rapid, ultrasensitive and visual detection of novel coronavirus SARS-CoV-2 and HIV virus, bioRxiv, 2020; 2020.03.19.998724
   Google Scholar
• Islam KU, Iqbal J. An update on molecular diagnostics for COVID-19. Front Cell Infect Microbiol. 2020;10:560616.
   PubMed Web of Science ®Google Scholar
• To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027–2034.
   PubMed Web of Science ®Google Scholar
• Tan W, Lu Y, Zhang J, et al. Viral kinetics and antibody responses in patients with COVID-19. medRxiv. 2020.
   Google Scholar
• Amanat F, Stadlbauer D, Strohmeier S, et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020;26(7):1033–1036.
   PubMed Web of Science ®Google Scholar
• Peterhoff D, Gluck V, Vogel M, et al. A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization. Infection. 2021;49(1):75–82.
   PubMed Web of Science ®Google Scholar
• Indenbaum V, Koren R, Katz-Likvornik S, et al. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis. PLoS One. 2020;15(11):e0241164.
   PubMed Web of Science ®Google Scholar
• Tre-Hardy M, Wilmet A, Beukinga I, et al. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. J Med Virol. 2021;93(2):803–811.
   PubMed Web of Science ®Google Scholar
• Risch M, Weber M, Thiel S, et al. Temporal course of SARS-CoV-2 antibody positivity in patients with COVID-19 following the first clinical presentation. Biomed Res Int. 2020;2020:9878453.
   PubMed Web of Science ®Google Scholar
• Van Elslande J, Houben E, Depypere M, et al. Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clin Microbiol Infect. 2020;26(8):1082–1087.
   PubMed Web of Science ®Google Scholar
• Kyosei Y, Namba M, Yamura S, et al. Proposal of De novo antigen test for COVID-19: ultrasensitive detection of spike proteins of SARS-CoV-2. Diagnostics (Basel). 2020;10(8):594.
   PubMedGoogle Scholar
• Mendoza R, Silver M, Zuretti AR, et al. Correlation of automated chemiluminescent method with enzyme-linked immunosorbent assay (ELISA) antibody titers in convalescent COVID-19 plasma samples: development of rapid, cost-effective semi-quantitative diagnostic methods. J Blood Med. 2021;12:157–164.
   PubMed Web of Science ®Google Scholar
• Tre-Hardy M, Wilmet A, Beukinga I, et al. Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody. Clin Chem Lab Med. 2020;58(8):1357–1364.
   PubMed Web of Science ®Google Scholar
• Ma H, Zeng W, He H, et al. Serum IgA, IgM, and IgG responses in COVID-19. Cell Mol Immunol. 2020;17(7):773–775.
   PubMed Web of Science ®Google Scholar
• Suhandynata RT, Hoffman MA, Kelner MJ, et al. Multi-platform comparison of SARS-CoV-2 serology assays for the detection of COVID-19. J Appl Lab Med. 2020;5(6):1324–1336.
   PubMedGoogle Scholar
• Soleimani R, Khourssaji M, Gruson D, et al. Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID-19 patients. J Med Virol. 2021;93(3):1465–1477.
   PubMed Web of Science ®Google Scholar
• Swadzba J, Bednarczyk M, Anyszek T, et al. The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays. Practical Laboratory Medicine. 2021;25:e00212.
   PubMedGoogle Scholar
• GeurtsvanKessel CH, Okba NMA, Igloi Z, et al. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nat Commun. 2020;11(1):3436.
   PubMed Web of Science ®Google Scholar
• Trabaud MA, Icard V, Milon MP, et al. Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody. J Clin Virol. 2020;132:104613.
   PubMed Web of Science ®Google Scholar
• Vauloup-Fellous C, Maylin S, Perillaud-Dubois C, et al. Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients. Eur J Clin Microbiol Infect Dis. 2021;40(10):2235–2241.
   PubMed Web of Science ®Google Scholar
• Lee SM, Kim IS, Lim S, et al. Comparison of serologic response of hospitalized COVID-19 patients using 8 immunoassays. J Korean Med Sci. 2021;36(9):e64.
   PubMed Web of Science ®Google Scholar
• Wu HS, Hsieh YC, Su IJ, et al. Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients. J Biomed Sci. 2004;11(1):117–126.
   PubMed Web of Science ®Google Scholar
• Cosgun Y, Altas AB, Kuzucu EA, et al. Role of rapid antibody and ELISA tests in the evaluation of serological response in patients with SARS-CoV-2 PCR positivity. Folia Microbiol (Praha). 2021;66(4):579–586.
   PubMed Web of Science ®Google Scholar
• Ghaffari A, Meurant R, Ardakani A. COVID-19 serological tests: how well do they actually perform? Diagnostics. 2020;10(7):453.
   Web of Science ®Google Scholar
• Lisboa Bastos M, Tavaziva G, Abidi SK, et al. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ. 2020;370:m2516.
   PubMed Web of Science ®Google Scholar
• Bendavid E, Mulaney B, Sood N, et al. COVID-19 antibody seroprevalence in Santa Clara County, California. Int J Epidemiol. 2021;50(2):410–419.
   PubMed Web of Science ®Google Scholar
• Boum Y, Fai KN, Nikolay B, et al. Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study. Lancet Infect Dis. 2021;21(8):1089–1096.
   PubMed Web of Science ®Google Scholar
• Mak GC, Cheng PK, Lau SS, et al. Evaluation of rapid antigen test for detection of SARS-CoV-2 virus. J Clin Virol. 2020;129:104500.
   PubMed Web of Science ®Google Scholar
• Bruzzone B, De Pace V, Caligiuri P, et al. Comparative diagnostic performance of rapid antigen detection tests for COVID-19 in a hospital setting. Int J Infect Dis. 2021;107:215–218.
   PubMed Web of Science ®Google Scholar
• Scohy A, Anantharajah A, Bodeus M, et al. Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis. J Clin Virol. 2020;129:104455.
   PubMed Web of Science ®Google Scholar
• Scheiblauer H, Filomena A, Nitsche A, et al. Comparative sensitivity evaluation for 122 CE-marked SARS-CoV-2 antigen rapid tests. medRxiv. 2021. 2021.05.11.21257016.
   Google Scholar
• Torres I, Poujois S, Albert E, et al. Evaluation of a rapid antigen test (Panbio COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Clin Microbiol Infect. 2021;27(4):636 e1- e4.
   PubMed Web of Science ®Google Scholar
• Pena M, Ampuero M, Garces C, et al. Performance of SARS-CoV-2 rapid antigen test compared with real-time RT-PCR in asymptomatic individuals. Int J Infect Dis. 2021;107:201–204.
   PubMed Web of Science ®Google Scholar
• McKay SL, Tobolowsky FA, Moritz ED, et al. Performance evaluation of serial SARS-CoV-2 rapid antigen testing during a nursing home outbreak. Ann Intern Med. 2021;174(7):945–951.
   PubMed Web of Science ®Google Scholar
• Smith RL, Gibson LL, Martinez PP, et al. Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection. J Infect Dis. 2021;224(6):976–982.
   PubMed Web of Science ®Google Scholar
• Linares M, Perez-Tanoira R, Carrero A, et al. Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. J Clin Virol. 2020;133:104659.
   PubMed Web of Science ®Google Scholar
• Jaafar R, Aherfi S, Wurtz N, et al. Correlation between 3790 quantitative polymerase chain reaction–positives samples and positive cell cultures, including 1941 severe acute respiratory syndrome coronavirus 2 isolates. Clinl Infect Dis. 2020;72(11):e921–e.
   Web of Science ®Google Scholar
• Hiroi S, Kubota-Koketsu R, Sasaki T, et al. Infectivity assay for detection of SARS-CoV-2 in samples from patients with COVID-19. J Med Virol. 2021;93(10):5917–5923.
   PubMed Web of Science ®Google Scholar
• Larremore DB, Wilder B, Lester E, et al. Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening. Sci Adv. 2021;7.
   Web of Science ®Google Scholar
• WHO. A compile of RT-PCR protocols for the detection of SARS-CoV-2. 2019.
   Google Scholar
• Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25(3):2000045.
   PubMedGoogle Scholar
• Nalla AK, Casto AM, Huang MW, et al. Comparative performance of SARS-CoV-2 detection assays using seven different primer-probe sets and one assay kit. J Clin Microbiol. 2020;58(6):e00557–20.
   PubMed Web of Science ®Google Scholar
• Penarrubia L, Ruiz M, Porco R, et al. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak. Int J Infect Dis. 2020;97:225–229.
   PubMed Web of Science ®Google Scholar
• Rana DR, Pokhrel N. Sequence mismatch in PCR probes may mask the COVID-19 detection in Nepal. Mol Cell Probes. 2020;53:101599.
   PubMed Web of Science ®Google Scholar
• Alvarez-Diaz DA, Franco-Munoz C, Laiton-Donato K, et al. Molecular analysis of several in-house rRT-PCR protocols for SARS-CoV-2 detection in the context of genetic variability of the virus in Colombia. Infect Genet Evol. 2020;84:104390.
   PubMed Web of Science ®Google Scholar
• Khan KA, Cheung P. Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome. R Soc Open Sci. 2020;7(6):200636.
   PubMed Web of Science ®Google Scholar
• Wang R, Hozumi Y, Yin C, et al. Mutations on COVID-19 diagnostic targets. Genomics. 2020;112(6):5204–5213.
   PubMed Web of Science ®Google Scholar
• Artesi M, Bontems S, Gobbels P, et al. A recurrent mutation at position 26340 of SARS-CoV-2 is associated with failure of the E gene quantitative reverse transcription-PCR utilized in a commercial dual-target diagnostic assay. J Clin Microbiol. 2020;58(10):e01598–20.
   PubMed Web of Science ®Google Scholar
• Ziegler K, Steininger P, Ziegler R, et al. SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene. Euro Surveill. 2020;25(39):2001650.
   PubMedGoogle Scholar
• Hasan MR, Sundararaju S, Manickam C, et al. A novel point mutation in the N gene of SARS-CoV-2 may affect the detection of the virus by reverse transcription-quantitative PCR. J Clin Microbiol. 2021;59(4):e03278–20.
   PubMed Web of Science ®Google Scholar
• Liu R, Wu P, Ogrodzki P, et al. Genomic epidemiology of SARS-CoV-2 in the UAE reveals novel virus mutation, patterns of co-infection and tissue specific host immune response. Sci Rep. 2021;11(1):13971.
   PubMed Web of Science ®Google Scholar
• Mourier T, Sadykov M, Carr MJ, et al. Host-directed editing of the SARS-CoV-2 genome. Biochem Biophys Res Commun. 2021;538:35–39.
   PubMed Web of Science ®Google Scholar
• Visseaux B, Le Hingrat Q, Collin G, et al. Evaluation of the QIAstat-Dx respiratory SARS-CoV-2 panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection. J Clin Microbiol. 2020;58(8):e00630–20.
   PubMed Web of Science ®Google Scholar
• Storey N, Brown JR, Pereira RPA, et al. Single base mutations in the nucleocapsid gene of SARS-CoV-2 affects amplification efficiency of sequence variants and may lead to assay failure. J Clin Virol Plus. 2021;1(3):100037.
   PubMedGoogle Scholar
• Alosaimi B, Naeem A, Hamed ME, et al. Influenza co-infection associated with severity and mortality in COVID-19 patients. Virol J. 2021;18(1):127.
   PubMed Web of Science ®Google Scholar
• Pabbaraju K, Wong AA, Ma R, et al. Development and validation of a multiplex reverse transcriptase-PCR assay for simultaneous testing of influenza A, influenza B and SARS-CoV-2. J Virol Methods. 2021;293:114151.
   PubMed Web of Science ®Google Scholar
• Norz D, Hoffmann A, Aepfelbacher M, et al. Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform. J Med Microbiol. 2021;70(2):001295.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang M, Yuan J, et al. Laboratory diagnosis and monitoring the viral shedding of SARS-CoV-2 infection. Innovation (N Y). 2020;1:100061.
   PubMedGoogle Scholar
• Wang X, Tan L, Wang X, et al. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously. Int J Infect Dis. 2020;94:107–109.
   PubMed Web of Science ®Google Scholar
• Wu J, Liu J, Li S, et al. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients. Travel Med Infect Dis. 2020;37:101673.
   PubMed Web of Science ®Google Scholar
• Casagrande M, Fitzek A, Puschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;28(5):721–725.
   PubMed Web of Science ®Google Scholar
• Meinhardt J, Radke J, Dittmayer C, et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci. 2021;24(2):168–175.
   PubMed Web of Science ®Google Scholar
• Song E, Zhang C, Israelow B, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218.
   Web of Science ®Google Scholar
• Green DA, Zucker J, Westblade LF, et al. Clinical Performance of SARS-CoV-2 Molecular Tests. J Clin Microbiol. 2020;58(8):e00995–20.
   PubMed Web of Science ®Google Scholar
• Lin C, Xiang J, Yan M, et al. Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2)-infected pneumonia (COVID-19). Clin Chem Lab Med. 2020;58(7):1089–1094.
   PubMed Web of Science ®Google Scholar
• Koskinen A, Tolvi M, Jauhiainen M, et al. Complications of COVID-19 nasopharyngeal swab test. JAMA Otolaryngol Head Neck Surg. 2021;147(7):672–674.
   PubMed Web of Science ®Google Scholar
• Tsang NNY, So HC, Ip DKM. Is oropharyngeal sampling a reliable test to detect SARS-CoV-2? – authors’ reply. Lancet Infect Dis. 2021;21(10):1348–1349.
   PubMed Web of Science ®Google Scholar
• Hanege FM, Kocoglu E, Kalcioglu MT, et al. SARS-CoV-2 presence in the saliva, tears, and cerumen of COVID −19 patients. Laryngoscope. 2021;131(5):E1677–E82.
   PubMed Web of Science ®Google Scholar
• Fougere Y, Schwob JM, Miauton A, et al. Performance of RT-PCR on saliva specimens compared with nasopharyngeal swabs for the detection of SARS-CoV-2 in children: a prospective comparative clinical trial. Pediatr Infect Dis J. 2021;40(8):e300–e4.
   PubMed Web of Science ®Google Scholar
• Pasomsub E, Watcharananan SP, Boonyawat K, et al. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Clin Microbiol Infect. 2021;27(2):285 e1- e4.
   PubMed Web of Science ®Google Scholar
• Teo AKJ, Choudhury Y, Tan IB, et al. Saliva is more sensitive than nasopharyngeal or nasal swabs for diagnosis of asymptomatic and mild COVID-19 infection. Sci Rep. 2021;11(1):3134.
   PubMed Web of Science ®Google Scholar
• Dogan OA, Kose B, Agaoglu NB, et al. Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs. J Virol Methods. 2021;290:114049.
   PubMed Web of Science ®Google Scholar
• Tan SH, Allicock O, Armstrong-Hough M, et al. Saliva as a gold-standard sample for SARS-CoV-2 detection. Lancet Respir Med. 2021;9(6):562–564.
   PubMed Web of Science ®Google Scholar
• Nacher M, Mergeay-Fabre M, Blanchet D, et al. Diagnostic accuracy and acceptability of molecular diagnosis of COVID-19 on saliva samples relative to nasopharyngeal swabs in tropical hospital and extra-hospital contexts: the COVISAL study. PLoS One. 2021;16(9):e0257169.
   PubMed Web of Science ®Google Scholar
• Lippi G, Simundic AM, Plebani M. Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020;58(7):1070–1076.
   PubMed Web of Science ®Google Scholar
• Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn. 2020;20(5):453–454.
   PubMed Web of Science ®Google Scholar
• Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology. 2020;296(2):E115–E7.
   PubMed Web of Science ®Google Scholar
• He JL, Luo L, Luo ZD, et al. Diagnostic performance between CT and initial real-time RT-PCR for clinically suspected 2019 coronavirus disease (COVID-19) patients outside Wuhan, China. Respir Med. 2020;168:105980.
   PubMed Web of Science ®Google Scholar
• Ren X, Liu Y, Chen H, et al. Application and optimization of RT-PCR in diagnosis of SARS-CoV-2 infection. medRxiv. 2020.
   Google Scholar
• Williams TC, Wastnedge E, McAllister G, et al. Sensitivity of RT-PCR testing of upper respiratory tract samples for SARS-CoV-2 in hospitalised patients: a retrospective cohort study. Wellcome Open Res. 2020;5:254.
   PubMedGoogle Scholar
• Munblit D, Nekliudov NA, Bugaeva P, et al. Stop COVID Cohort: an Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection. Clinl Infect Dis. 2020;73(1):1–11.
   Web of Science ®Google Scholar
• Kortela E, Kirjavainen V, Ahava MJ, et al. Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients. PLoS One. 2021;16(5):e0251661.
   PubMed Web of Science ®Google Scholar
• Bergmans BJM, Reusken C, van Oudheusden AJG, et al. Test, trace, isolate: evidence for declining SARS-CoV-2 PCR sensitivity in a clinical cohort. Diagn Microbiol Infect Dis. 2021;101(2):115392.
   PubMed Web of Science ®Google Scholar
• LeBlanc JJ, Pettipas J, Di Quinzio M, et al. Reliable detection of SARS-CoV-2 with patient-collected swabs and saline gargles: a three-headed comparison on multiple molecular platforms. J Virol Methods. 2021;295:114184.
   PubMed Web of Science ®Google Scholar
• Braz-Silva PH, Mamana AC, Romano CM, et al. Performance of at-home self-collected saliva and nasal-oropharyngeal swabs in the surveillance of COVID-19. J Oral Microbiol. 2020;13(1):1858002.
   PubMed Web of Science ®Google Scholar
• SoRelle JA, Mahimainathan L, McCormick-Baw C, et al. Saliva for use with a point of care assay for the rapid diagnosis of COVID-19. Clin Chim Acta. 2020;510:685–686.
   PubMed Web of Science ®Google Scholar
• Smyrlaki I, Ekman M, Lentini A, Rufino de Sousa N, Papanicolaou N, Vondracek M, et al. Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR. Nat Commun. 2020;11:4812.
   PubMed Web of Science ®Google Scholar
• Adams NM, Leelawong M, Benton A, et al. COVID-19 diagnostics for resource-limited settings: evaluation of “unextracted” qRT-PCR. J Med Virol. 2021;93(1):559–563.
   PubMed Web of Science ®Google Scholar
• Byrnes SA, Gallagher R, Steadman A, et al. Multiplexed and extraction-free amplification for simplified SARS-CoV-2 RT-PCR tests. Anal Chem. 2021;93(9):4160–4165.
   PubMed Web of Science ®Google Scholar
• Visseaux B, Collin G, Houhou-Fidouh N, et al. Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: a feasible alternative approach with low technical requirements. J Virol Methods. 2021;291:114086.
   PubMed Web of Science ®Google Scholar
• Lubke N, Senff T, Scherger S, et al. Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials. J Clin Virol. 2020;130:104579.
   PubMed Web of Science ®Google Scholar
• Renzoni A, Perez F, Ngo Nsoga MT, et al. Analytical evaluation of visby medical RT-PCR portable device for rapid detection of SARS-CoV-2. Diagnostics (Basel). 2021;11(5):813.
   PubMedGoogle Scholar
• Gibani MM, Toumazou C, Sohbati M, et al. Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study. Lancet Microbe. 2020;1(7):e300–e7.
   PubMedGoogle Scholar
• Wee SK, Sivalingam SP, Yap EPH. Rapid direct nucleic acid amplification test without RNA extraction for SARS-CoV-2 using a portable PCR thermocycler. Genes (Basel). 2020;11(6):664.
   PubMed Web of Science ®Google Scholar
• Cuevas-Ferrando E, Randazzo W, Perez-Cataluna A, et al. Platinum chloride-based viability RT-qPCR for SARS-CoV-2 detection in complex samples. Sci Rep. 2021;11(1):18120.
   PubMed Web of Science ®Google Scholar
• Libin PJK, Willem L, Verstraeten T, et al. Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics. PLoS Comput Biol. 2021;17(3):e1008688.
   PubMed Web of Science ®Google Scholar
• Lyng GD, Sheils NE, Kennedy CJ, et al. Identifying optimal COVID-19 testing strategies for schools and businesses: balancing testing frequency, individual test technology, and cost. PLoS One. 2021;16(3):e0248783.
   PubMed Web of Science ®Google Scholar
• Stohr JJ, Wennekes M, van der Ent M, et al. Clinical performance and sample freeze-thaw stability of the cobas® 6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens. J Clin Virol. 2020;133:104686.
   PubMed Web of Science ®Google Scholar
• Hirschhorn JW, Kegl A, Dickerson T, et al. Verification and validation of SARS-CoV-2 assay performance on the abbott m 2000 and alinity m systems. J Clin Microbiol. 2021;59(5):e03119–20.
   PubMed Web of Science ®Google Scholar
• Goldenberger D, Leuzinger K, Sogaard KK, et al. Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay. J Virol Methods. 2020;284:113925.
   PubMed Web of Science ®Google Scholar
• Mostafa HH, Hardick J, Morehead E, et al. Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays. J Clin Virol. 2020;130:104578.
   PubMed Web of Science ®Google Scholar
• Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):E63.
   PubMed Web of Science ®Google Scholar
• Li J, Hu X, Wang X, et al. A novel One-pot rapid diagnostic technology for COVID-19. Anal Chim Acta. 2021;1154:338310.
   PubMed Web of Science ®Google Scholar
• Lamb LE, Bartolone SN, Ward E, et al. Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification. PLoS One. 2020;15(6):e0234682.
   PubMed Web of Science ®Google Scholar
• Baek YH, Um J, Antigua KJC, et al. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2. Emerg Microbes Infect. 2020;9(1):998–1007.
   PubMed Web of Science ®Google Scholar
• Yu L, Wu S, Hao X, et al. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform. Clin Chem. 2020;66(7):975–977.
   PubMed Web of Science ®Google Scholar
• Rodel J, Egerer R, Suleyman A, et al. Use of the variplex SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis. J Clin Virol. 2020;132:104616.
   PubMed Web of Science ®Google Scholar
• Dao Thi VL, Herbst K, Boerner K, et al. A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples. Sci Transl Med. 2020;12(556):eabc7075.
   PubMed Web of Science ®Google Scholar
• Jiang M, Pan W, Arasthfer A, et al. Development and validation of a rapid, single-step reverse transcriptase loop-mediated isothermal amplification (RT-LAMP) system potentially to be used for reliable and high-throughput screening of COVID-19. Front Cell Infect Microbiol. 2020;10:331.
   PubMed Web of Science ®Google Scholar
• Chow FW, Chan TT, Tam AR, et al. A rapid, simple, inexpensive, and mobile colorimetric assay COVID-19-LAMP for mass on-site screening of COVID-19. Int J Mol Sci. 2020;21(15):5380.
   PubMed Web of Science ®Google Scholar
• Kitagawa Y, Orihara Y, Kawamura R, et al. Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification. J Clin Virol. 2020;129:104446.
   PubMed Web of Science ®Google Scholar
• Tran DH, Cuong HQ, Tran HT, et al. A comparative study of isothermal nucleic acid amplification methods for SARS-CoV-2 detection at point-of-care. bioRxiv. 2021.
   Google Scholar
• Carter C, Akrami K, Hall D, et al. Lyophilized visually readable loop-mediated isothermal reverse transcriptase nucleic acid amplification test for detection Ebola Zaire RNA. J Virol Methods. 2017;244:32–38.
   PubMed Web of Science ®Google Scholar
• Chen HW, Ching WM. Evaluation of the stability of lyophilized loop-mediated isothermal amplification reagents for the detection of Coxiella burnetii. Heliyon. 2017;3(10):e00415.
   PubMed Web of Science ®Google Scholar
• Aoki MN, de Oliveira Coelho B, Goes LGB, et al. Colorimetric RT-LAMP SARS-CoV-2 diagnostic sensitivity relies on color interpretation and viral load. Sci Rep. 2021;11(1):9026.
   PubMed Web of Science ®Google Scholar
• Silva LDC, Dos Santos CA, Mendes GM, et al. Can a field molecular diagnosis be accurate? A performance evaluation of colorimetric RT-LAMP for the detection of SARS-CoV-2 in a hospital setting. Anal Methods: Adv Methods Appl. 2021;13(26):2898–2907.
   Google Scholar
• Piepenburg O, Williams CH, Stemple DL, et al. DNA detection using recombination proteins. PLoS Biol. 2006;4(7):e204.
   PubMed Web of Science ®Google Scholar
• Xia S, Chen X. Single-copy sensitive, field-deployable, and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA. Cell Discov. 2020;6(1):37.
   PubMed Web of Science ®Google Scholar
• Lau YL, Ismail IB, Mustapa NIB, et al. Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). PLoS One. 2021;16(1):e0245164.
   PubMed Web of Science ®Google Scholar
• Van Ness J, Van Ness LK, Galas DJ. Isothermal reactions for the amplification of oligonucleotides. Proc Natl Acad Sci U S A. 2003;100(8):4504–4509.
   PubMed Web of Science ®Google Scholar
• Wang L, Qian C, Wu H, et al. Technical aspects of nicking enzyme assisted amplification. Analyst. 2018;143(6):1444–1453.
   PubMed Web of Science ®Google Scholar
• Serei VD, Cristelli R, Joho K, et al. Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs. Diagn Microbiol Infect Dis. 2021;99(4):115208.
   PubMed Web of Science ®Google Scholar
• Basu A, Zinger T, Inglima K, et al. Performance of Abbott ID Now COVID-19 rapid nucleic acid amplification test using nasopharyngeal swabs transported in viral transport media and dry nasal swabs in a New York city academic institution. J Clin Microbiol. 2020;58(8):e01136–20.
   PubMed Web of Science ®Google Scholar
• Harrington A, Cox B, Snowdon J, et al. Comparison of Abbott ID now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients. J Clin Microbiol. 2020;58(8):e00798–20.
   PubMed Web of Science ®Google Scholar
• Rhoads DD, Cherian SS, Roman K, et al. Comparison of Abbott ID now, diasorin simplexa, and CDC FDA emergency use authorization methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19. J Clin Microbiol. 2020;58(8):e00760–20.
   PubMed Web of Science ®Google Scholar
• Smithgall MC, Scherberkova I, Whittier S, et al. Comparison of cepheid xpert Xpress and Abbott ID now to roche cobas for the rapid detection of SARS-CoV-2. J Clin Virol. 2020;128:104428.
   PubMed Web of Science ®Google Scholar
• Zhen W, Smith E, Manji R, et al. Clinical evaluation of three sample-to-answer platforms for detection of SARS-CoV-2. J Clin Microbiol. 2020;58(8):e00783–20.
   PubMed Web of Science ®Google Scholar
• Tu YP, Iqbal J, O’Leary T. Sensitivity of ID NOW and RT-PCR for detection of SARS-CoV-2 in an ambulatory population. Elife. 2021;10:e65726.
   PubMed Web of Science ®Google Scholar
• Naveen KP, Bhat AI. Development of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and reverse transcription recombinase polymerase amplification (RT-RPA) assays for the detection of two novel viruses infecting ginger. J Virol Methods. 2020;282:113884.
   PubMed Web of Science ®Google Scholar
• Naveen KP, Bhat AI. Reverse transcriptase loop-mediated isothermal amplification and reverse transcriptase recombinase amplification assays for rapid and sensitive detection of cardamom vein clearing virus. 3 Biotech. 2020;10(6):250.
   PubMedGoogle Scholar
• Kobayashi GS, Brito LA, Moreira DP, et al. A Novel Saliva RT-LAMP Workflow for Rapid Identification of COVID-19 Cases and Restraining Viral Spread. Diagnostics (Basel). 2021;11(8):1400.
   PubMedGoogle Scholar
• Toppings NB, Mohon AN, Lee Y, et al. A rapid near-patient detection system for SARS-CoV-2 using saliva. Sci Rep. 2021;11(1):13378.
   PubMed Web of Science ®Google Scholar
• Soto F, Ozen MO, Guimaraes CF, et al. Wearable collector for noninvasive sampling of SARS-CoV-2 from exhaled breath for rapid detection. ACS Appl Mater Interfaces. 2021;13(35):41445–41453.
   PubMed Web of Science ®Google Scholar
• Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007;315(5819):1709–1712.
   PubMed Web of Science ®Google Scholar
• Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science. 2010;327(5962):167–170.
   PubMed Web of Science ®Google Scholar
• McGinn J, Marraffini LA. CRISPR-cas systems optimize their immune response by specifying the site of spacer integration. Mol Cell. 2016;64(3):616–623.
   PubMed Web of Science ®Google Scholar
• Koonin EV, Makarova KS, Zhang F. Diversity, classification and evolution of CRISPR-Cas systems. Curr Opin Microbiol. 2017;37:67–78.
   PubMed Web of Science ®Google Scholar
• Cong L, Ran FA, Cox D, et al. Multiplex genome engineering using CRISPR/Cas systems. Science. 2013;339(6121):819–823.
   PubMed Web of Science ®Google Scholar
• Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337(6096):816–821.
   PubMed Web of Science ®Google Scholar
• Singh V, Braddick D, Dhar PK. Exploring the potential of genome editing CRISPR-Cas9 technology. Gene. 2017;599:1–18.
   PubMed Web of Science ®Google Scholar
• Singh V, Gohil N, Ramirez Garcia R, et al. Recent advances in CRISPR-Cas9 genome editing technology for biological and biomedical investigations. J Cell Biochem. 2018;119(1):81–94.
   PubMed Web of Science ®Google Scholar
• Bikard D, Euler CW, Jiang W, et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol. 2014;32(11):1146–1150.
   PubMed Web of Science ®Google Scholar
• Citorik RJ, Mimee M, Lu TK. Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol. 2014;32(11):1141–1145.
   PubMed Web of Science ®Google Scholar
• Yosef I, Manor M, Kiro R, et al. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci U S A. 2015;112(23):7267–7272.
   PubMed Web of Science ®Google Scholar
• Ebina H, Misawa N, Kanemura Y, et al. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep. 2013;3(1):2510.
   PubMedGoogle Scholar
• Zhu W, Lei R, Le Duff Y, et al. The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology. 2015;12(1):22.
   PubMedGoogle Scholar
• Kennedy EM, Bassit LC, Mueller H, et al. Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease. Virology. 2015;476:196–205.
   PubMed Web of Science ®Google Scholar
• Lin S, Yu Z, Chen D, et al. Progress in microfluidics-based exosome separation and detection technologies for diagnostic applications. Small. 2020;16(9):e1903916.
   PubMed Web of Science ®Google Scholar
• Abbott TR, Dhamdhere G, Liu Y, et al. Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and Influenza. Cell. 2020;181(4):865–76 e12.
   PubMed Web of Science ®Google Scholar
• Chen JS, Ma E, Harrington LB, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018;360(6387):436–439.
   PubMed Web of Science ®Google Scholar
• Shmakov S, Smargon A, Scott D, et al. Diversity and evolution of class 2 CRISPR-Cas systems. Nat Rev Microbiol. 2017;15(3):169–182.
   PubMed Web of Science ®Google Scholar
• Abudayyeh OO, Gootenberg JS, Essletzbichler P, et al. RNA targeting with CRISPR-Cas13. Nature. 2017;550(7675):280–284.
   PubMed Web of Science ®Google Scholar
• Cox DBT, Gootenberg JS, Abudayyeh OO, et al. RNA editing with CRISPR-Cas13. Science. 2017;358(6366):1019–1027.
   PubMed Web of Science ®Google Scholar
• Kellner MJ, Koob JG, Gootenberg JS, et al. SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc. 2019;14(10):2986–3012.
   PubMed Web of Science ®Google Scholar
• Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 2018;360:439–444.
   Google Scholar
• Gootenberg JS, Abudayyeh OO, Lee JW, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 2017;356(6336):438–442.
   PubMed Web of Science ®Google Scholar
• de Puig H, Lee RA, Najjar D, et al. Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants. Sci Adv. 2021;7(32):eabh2944.
   PubMed Web of Science ®Google Scholar
• Khambhati K, Bhattacharjee G, Singh V. Current progress in CRISPR-based diagnostic platforms. J Cell Biochem. 2019;120(3):2721–2725.
   PubMed Web of Science ®Google Scholar
• Broughton JP, Deng X, Yu G, et al. CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020;38(7):870–874.
   PubMed Web of Science ®Google Scholar
• Ding X, Yin K, Li Z, et al. Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay. Nat Commun. 2020;11(1):4711.
   PubMed Web of Science ®Google Scholar
• Huang Z, Tian D, Liu Y, et al. Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis. Biosens Bioelectron. 2020;164:112316.
   PubMed Web of Science ®Google Scholar
• Chen Y, Shi Y, Chen Y, et al. Contamination-free visual detection of SARS-CoV-2 with CRISPR/Cas12a: a promising method in the point-of-care detection. Biosens Bioelectron. 2020;169:112642.
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu J, Zhou X. A CRISPR-based and post-amplification coupled SARS-CoV-2 detection with a portable evanescent wave biosensor. Biosens Bioelectron. 2021;190:113418.
   PubMed Web of Science ®Google Scholar
• Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32(8):760–772.
   PubMed Web of Science ®Google Scholar
• Carrera J, Rodrigo G, Singh V, et al. Empirical model and in vivo characterization of the bacterial response to synthetic gene expression show that ribosome allocation limits growth rate. Biotechnol J. 2011;6(7):773–783.
   PubMed Web of Science ®Google Scholar
• Kim JA, Lee JY, Seong S, et al. Fabrication and characterization of a PDMS–glass hybrid continuous-flow PCR chip. Biochem Eng J. 2006;29(1–2):91–97.
   Web of Science ®Google Scholar
• Wolf MP, Salieb-Beugelaar GB, Hunziker P. PDMS with designer functionalities—Properties, modifications strategies, and applications. Prog Polym Sci. 2018;83:97–134.
   Web of Science ®Google Scholar
• Mao K, Min X, Zhang H, et al. Paper-based microfluidics for rapid diagnostics and drug delivery. J Control Release. 2020;322:187–199.
   PubMed Web of Science ®Google Scholar
• Sackmann EK, Fulton AL, Beebe DJ. The present and future role of microfluidics in biomedical research. Nature. 2014;507(7491):181–189.
   PubMed Web of Science ®Google Scholar
• Taylor BJ, Howell A, Martin KA, et al. A lab-on-chip for malaria diagnosis and surveillance. Malar J. 2014;13(1):179.
   PubMedGoogle Scholar
• Zhuang J, Yin J, Lv S, et al. Advanced “lab-on-a-chip” to detect viruses - Current challenges and future perspectives. Biosens Bioelectron. 2020;163:112291.
   PubMed Web of Science ®Google Scholar
• Basiri A, Heidari A, Nadi MF, et al. Microfluidic devices for detection of RNA viruses. Rev Med Virol. 2021;31(1):1–11.
   PubMed Web of Science ®Google Scholar
• Ferguson BS, Buchsbaum SF, Wu TT, et al. Genetic analysis of H1N1 influenza virus from throat swab samples in a microfluidic system for point-of-care diagnostics. J Am Chem Soc. 2011;133(23):9129–9135.
   PubMed Web of Science ®Google Scholar
• Brassard D, Geissler M, Descarreaux M, et al. Extraction of nucleic acids from blood: unveiling the potential of active pneumatic pumping in centrifugal microfluidics for integration and automation of sample preparation processes. Lab Chip. 2019;19(11):1941–1952.
   PubMed Web of Science ®Google Scholar
• Geissler M, Brassard D, Clime L, et al. Centrifugal microfluidic lab-on-a-chip system with automated sample lysis, DNA amplification and microarray hybridization for identification of enterohemorrhagic Escherichia coli culture isolates. Analyst. 2020;145:6831–6845.
   PubMed Web of Science ®Google Scholar
• Sullivan BP, Bender AT, Ngyuen DN, et al. Nucleic acid sample preparation from whole blood in a paper microfluidic device using isotachophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1163:122494.
   PubMed Web of Science ®Google Scholar
• Qiu X, Zhang S, Xiang F, et al. Instrument-free point-of-care molecular diagnosis of H1N1 based on microfluidic convective PCR. Sens Actuators B Chem. 2017;243:738–744.
   Web of Science ®Google Scholar
• Rodriguez-Moncayo R, Cedillo-Alcantar DF, Guevara-Pantoja PE, et al. A high-throughput multiplexed microfluidic device for COVID-19 serology assays. Lab Chip. 2021;21(1):93–104.
   PubMed Web of Science ®Google Scholar
• Funari R, Chu KY, Shen AQ. Detection of antibodies against SARS-CoV-2 spike protein by gold nanospikes in an opto-microfluidic chip. Biosens Bioelectron. 2020;169:112578.
   PubMed Web of Science ®Google Scholar
• Lin Q, Wen D, Wu J, et al. Microfluidic immunoassays for sensitive and simultaneous detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min. Anal Chem. 2020;92(14):9454–9458.
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Huyke DA, Sharma E, et al. Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2. Proc Natl Acad Sci U S A. 2020;117(47):29518–29525.
   PubMed Web of Science ®Google Scholar
• Mavrikou S, Tsekouras V, Hatziagapiou K, et al. Clinical application of the novel cell-based biosensor for the ultra-rapid detection of the SARS-CoV-2 S1 spike protein antigen: a practical approach. Biosensors (Basel). 2021;11(7):224.
   PubMedGoogle Scholar
• Agarwal DK, Nandwana V, Henrich SE, et al. Highly sensitive and ultra-rapid antigen-based detection of SARS-CoV-2 using nanomechanical sensor platform. Biosens Bioelectron. 2021;113647.
   PubMedGoogle Scholar
• Raziq A, Kidakova A, Boroznjak R, et al. Development of a portable MIP-based electrochemical sensor for detection of SARS-CoV-2 antigen. Biosens Bioelectron. 2021;178:113029.
   PubMed Web of Science ®Google Scholar
• Nurputra DK, Kusumaatmadja A, Hakim MS, et al. Fast and noninvasive electronic nose for sniffing out COVID-19 based on exhaled breath-print recognition. Res Square. 2021.
   Google Scholar
• De Lima LF, Ferreira AL, Torres MDT, et al. Minute-scale detection of SARS-CoV-2 using a low-cost biosensor composed of pencil graphite electrodes. PNAS. 2021;118(30):e2106724118.
   PubMed Web of Science ®Google Scholar
• Nguyen NHL, Kim S, Lindemann G, et al. COVID-19 spike protein induced phononic modification in antibody-coupled graphene for viral detection application. ACS Nano. 2021;15(7):11743–11752.
   PubMed Web of Science ®Google Scholar
• Hwang MT, Park I, Heiranian M, et al. Ultrasensitive detection of dopamine, IL‐6 and SARS‐CoV‐2 proteins on crumpled graphene FET biosensor. Adv Mater Technol. 2021;2100712:2100712.
   Google Scholar
• Nguyen PQ, Soenksen LR, Donghia NM, et al. Wearable materials with embedded synthetic biology sensors for biomolecule detection. Nat Biotechnol. 2021. DOI:10.1038/s41587-021-00950-3.
   Web of Science ®Google Scholar
• Ye Z, Zhang Y, Wang Y, et al. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020;30(8):4381–4389.
   PubMed Web of Science ®Google Scholar
• Saeed GA, Gaba W, Shah A, et al. Correlation between Chest CT Severity Scores and the Clinical Parameters of Adult Patients with COVID-19 Pneumonia. Radiol Res Pract. 2021;2021:6697677.
   PubMed Web of Science ®Google Scholar
• Kovacs A, Palasti P, Vereb D, et al. The sensitivity and specificity of chest CT in the diagnosis of COVID-19. Eur Radiol. 2021;31(5):2819–2824.
   PubMed Web of Science ®Google Scholar
• Saba L, Agarwal M, Patrick A, et al. Six artificial intelligence paradigms for tissue characterisation and classification of non-COVID-19 pneumonia against COVID-19 pneumonia in computed tomography lungs. Int J Comput Assist Radiol Surg. 2021;16(3):423–434.
   PubMed Web of Science ®Google Scholar
• Song Y, Zheng S, Li L, et al. Deep learning enables accurate diagnosis of novel coronavirus (COVID-19) with CT images. IEEE/ACM Transactions on Computational Biology and Bioinformatics 2021 1 10.1109/TCBB.2021.3065361
   Web of Science ®Google Scholar
• Jaiswal A, Gianchandani N, Singh D, et al. Classification of the COVID-19 infected patients using DenseNet201 based deep transfer learning. J Biomol Struct Dyn. 2021;39(15):5682–5689.
   PubMed Web of Science ®Google Scholar
• Wang S, Kang B, Ma J, et al. A deep learning algorithm using CT images to screen for Corona virus disease (COVID-19). Eur Radiol. 2021;31(8):6096–6104.
   PubMed Web of Science ®Google Scholar
• Abbas A, Abdelsamea MM, Gaber MM. Classification of COVID-19 in chest X-ray images using DeTraC deep convolutional neural network. Appl Intell. 2020;51(2):854–864.
   PubMed Web of Science ®Google Scholar
• Chen J, Wu L, Zhang J, et al. Deep learning-based model for detecting 2019 novel coronavirus pneumonia on high-resolution computed tomography. Sci Rep. 2020;10(1):19196.
   PubMed Web of Science ®Google Scholar
• Shan F, Gao Y, Wang J, et al. Lung infection quantification of COVID-19 in CT images with deep learning. arXiv Preprint. 2020.
   Google Scholar
• Laguarta J, Hueto F, Subirana B. COVID-19 artificial intelligence diagnosis using only cough recordings. IEEE Open Journal of Engineering in Medicine and Biology. 2020;1:275–281.
   PubMedGoogle Scholar
• Orlandic L, Teijeiro T, Atienza D. The COUGHVID crowdsourcing dataset, a corpus for the study of large-scale cough analysis algorithms. Sci Data. 2021;8(1):156.
   PubMed Web of Science ®Google Scholar
• Sharma N, PrashantKrishnan V, Kumar R, et al. Coswara - A Database of Breathing, Cough, and Voice Sounds for COVID-19 Diagnosis. In: INTERSPEECH. 2020.
   Google Scholar
• FDA. Coronavirus (COVID-19) Update: July 23, 2021. 2021.
   Google Scholar